Melola Discovery

← Melola Discovery

Open access Journal SINTA 1

Design and Computational Analysis of 2-Chlorobenzoylated Quercetin Derivatives as Inhibitors of Estrogen Receptor Alpha

Indonesian Journal of Chemistry · Vol. 26 No. 3 (2026) · pp. 855–855

DOI
10.22146/ijc.111483
ISSN
1411-9420, 2460-1578
Published
2026-06-01
Publisher
Gadjah Mada University
Language
en
License
creativecommons.org/licenses/by-nc-nd/4.0/

Abstract

Breast cancer remains a leading cause of mortality in women, highlighting the need for novel therapeutics. Quercetin, a natural flavonoid, shows anticancer potential but suffers from poor pharmacokinetics. To enhance its activity, 23 quercetin derivatives were designed as the flavonoid derivatives (FLD) series and evaluated using an integrated in silico workflow, including Lipinski’s rule-of-five assessment, molecular docking against the estrogen receptor alpha (ERα; PDB ID: 3ERT), and ADMET prediction. Based on docking scores and favorable ADMET profiles, FLD-4, FLD-5, and FLD-6 were selected for 100 ns molecular dynamics simulations. FLD-4 exhibited the highest stability with an average RMSD of approximately 0.30 nm, while FLD-6 showed larger fluctuations (0.45 nm). SASA analysis revealed more compact structures for FLD-4 and the control ligand (131–133 nm2) compared to quercetin and FLD-6. RMSF analysis confirmed reduced terminal residue flexibility for FLD-4 and FLD-5 ( 1.0 nm. MM-PBSA analysis further identified FLD-4 as the most stable complex (−205.409 ± 17.844 kJ/mol). Collectively, these results indicate that FLD-4 forms a stable, compact complex with improved binding affinity and drug-likeness, supporting its potential as a lead compound for flavonoid-based breast cancer therapy.

Keywords

Collaboration network of the authors

40 authors · 133 co-authorship links · 56 across different organisations · showing the 40 most connected

Hover or tap a name to highlight its co-authors. Double-click to open the author's page.

  • Universitas Ahmad Dahlan
  • State University of Semarang
  • Poltekkes Kemenkes Palangka Raya
  • Sebelas Maret University
  • Jenderal Soedirman University
  • Muhammadiyah University of Yogyakarta
  • Universitas Gadjah Mada
  • Other organisations
  • Affiliation unknown
  • Different organisations
  • Same organisation
  • Affiliation unknown
  • Thicker line = more joint articles · bigger circle = more articles
Show as table
Co-authorOrganisationJoint articles
Akrom AkromUniversitas Ahmad Dahlan5
Titiek HidayatiMuhammadiyah University of Yogyakarta4
Dyah Aryani PerwitasariUniversitas Ahmad Dahlan2
Sitarina WidyariniUniversitas Gadjah Mada2
Ari WahyudiUniversitas Ahmad Dahlan2
Andika AndikaUniversitas Islam Negeri Sulthan Thaha Saifuddin Jambi2
Nurkhasanah MahfudhUniversitas Ahmad Dahlan2
Siti NashihahUniversitas Muhammadiyah Banjarmasin2
Giriani Ayu SabillaUniversitas Ahmad Dahlan2
Nurkhasanah NurkhasanahAffiliation unknown2
Ikhwan Dahlan RaisAffiliation unknown2
Langlang HandayaniState University of Semarang1
Fianti FiantiState University of Semarang1
Husna ArifahYogyakarta State University1
Delvananta GivarinState University of Semarang1
Normila NormilaPoltekkes Kemenkes Palangka Raya1
Cindra Ainie TsabithaPoltekkes Kemenkes Palangka Raya1
Ika MaryaniUniversitas Ahmad Dahlan1
Amalya Nurul KhairiUniversitas Ahmad Dahlan1
Handewi Purwati SaliemNational Research and Innovation Agency1
Hasan DjiduUniversitas Sembilanbelas November Kolaka1
Rita MalizaAndalas University1
Bramadi AryaMahidol University1
Haafizah DaniaUniversitas Ahmad Dahlan1
Jaka PradikaAffiliation unknown1
Kharisma PratamaInstitut Teknologi dan Kesehatan Muhammadiyah Kalimantan Barat1
Kusnandar KusnandarSebelas Maret University1
Diffah HanimSebelas Maret University1
Sunarti SunartiUniversitas Ahmad Dahlan1
Ahid MudayanaUniversitas Ahmad Dahlan1

Affiliations come from OpenAlex; journal OAI-PMH metadata carries none. Authors without an OpenAlex ID are matched by name, which can merge or split people.

Metadata source: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S2764840418, first harvested 19 Nov 2026, last seen 19 Nov 2026.
Original metadata (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">Design and Computational Analysis of 2-Chlorobenzoylated Quercetin Derivatives as Inhibitors of Estrogen Receptor Alpha</dc:title><dc:creator>Dwi Utami</dc:creator><dc:creator>Muhammad Fauzi</dc:creator><dc:creator>Laela Hayu Nurani</dc:creator><dc:creator>Any Guntarti</dc:creator><dc:creator>Citra Ariani Edityaningrum</dc:creator><dc:creator>Sugiyanto Sugiyanto</dc:creator><dc:creator>Lalu Muhammad Irham</dc:creator><dc:creator>Mustofa Ahda</dc:creator><dc:creator>Fara Azzahra</dc:creator><dc:creator>Arif Budi Setianto</dc:creator><dc:subject>quercetin derivatives</dc:subject><dc:subject>estrogen receptor alpha</dc:subject><dc:subject>breast cancer</dc:subject><dc:subject>flavonoid derivatives</dc:subject><dc:subject>molecular docking</dc:subject><dc:subject>molecular dynamics simulation</dc:subject><dc:subject>MM-PBSA binding free energy</dc:subject><dc:subject>ADMET prediction</dc:subject><dc:subject>drug-likeness</dc:subject><dc:subject>lead compound design</dc:subject><dc:subject>anticancer agents</dc:subject><dc:description xml:lang="en">Breast cancer remains a leading cause of mortality in women, highlighting the need for novel therapeutics. Quercetin, a natural flavonoid, shows anticancer potential but suffers from poor pharmacokinetics. To enhance its activity, 23 quercetin derivatives were designed as the flavonoid derivatives (FLD) series and evaluated using an integrated in silico workflow, including Lipinski’s rule-of-five assessment, molecular docking against the estrogen receptor alpha (ERα; PDB ID: 3ERT), and ADMET prediction. Based on docking scores and favorable ADMET profiles, FLD-4, FLD-5, and FLD-6 were selected for 100 ns molecular dynamics simulations. FLD-4 exhibited the highest stability with an average RMSD of approximately 0.30 nm, while FLD-6 showed larger fluctuations (0.45 nm). SASA analysis revealed more compact structures for FLD-4 and the control ligand (131–133 nm2) compared to quercetin and FLD-6. RMSF analysis confirmed reduced terminal residue flexibility for FLD-4 and FLD-5 (&lt; 0.9 nm), whereas quercetin and FLD-6 fluctuated &gt; 1.0 nm. MM-PBSA analysis further identified FLD-4 as the most stable complex (−205.409 ± 17.844 kJ/mol). Collectively, these results indicate that FLD-4 forms a stable, compact complex with improved binding affinity and drug-likeness, supporting its potential as a lead compound for flavonoid-based breast cancer therapy.</dc:description><dc:publisher>Gadjah Mada University</dc:publisher><dc:date>2026-06-01</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.22146/ijc.111483</dc:identifier><dc:identifier>10.22146/ijc.111483</dc:identifier><dc:source>Indonesian Journal of Chemistry; Vol 26 No 3 (2026); 855-855</dc:source><dc:source>1411-9420</dc:source><dc:source>2460-1578</dc:source><dc:language>en</dc:language><dc:relation>https://journal.ugm.ac.id/ijc/article/download/111483/43595</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc-nd/4.0/</dc:rights></oai_dc:dc>